Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus

BACKGROUND: Recently, basic and clinical studies have provided evidence supporting the relationship between circulating levels of fibroblast growth factor (FGF) 23 and the development of atherosclerosis. Given that diabetes is an established risk factor for lower extremity atherosclerotic disease (L...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cardiovasc Diabetol
Main Authors: He, Xingxing, Hu, Xiang, Ma, Xiaojing, Su, Hang, Ying, Lingwen, Peng, Jiahui, Pan, Xiaoping, Bao, Yuqian, Zhou, Jian, Jia, Weiping
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5472967/
https://ncbi.nlm.nih.gov/pubmed/28619026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-017-0559-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados